Pi Y - Search Results

1

A Novel Notch-Related Gene Signature for Prognosis and Immune Response Prediction in Ovarian Cancer.

Pi Y, Sun F, Zhang Z, Liu X, Lou G. Pi Y, et al. Medicina (Kaunas). 2023 Jul 9;59(7):1277. doi: 10.3390/medicina59071277. Medicina (Kaunas). 2023. PMID: 37512088 Free PMC article.

2

Exosomes: Powerful weapon for cancer nano-immunoengineering.

Pi YN, Xia BR, Jin MZ, Jin WL, Lou G. Pi YN, et al. Biochem Pharmacol. 2021 Apr;186:114487. doi: 10.1016/j.bcp.2021.114487. Epub 2021 Feb 27. Biochem Pharmacol. 2021. PMID: 33647264 Review.

3

Development and Validation of a Prognostic Signature Based on Immune Genes in Cervical Cancer.

Chen Y, Lin H, Pi YN, Chen XX, Zhou H, Tian Y, Zhao WD, Xia BR. Chen Y, et al. Among authors: pi yn. Front Oncol. 2021 Mar 17;11:616530. doi: 10.3389/fonc.2021.616530. eCollection 2021. Front Oncol. 2021. PMID: 33842318 Free PMC article.

4

Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic Potential.

Pi YN, Qi WC, Xia BR, Lou G, Jin WL. Pi YN, et al. Front Immunol. 2021 Jul 6;12:697083. doi: 10.3389/fimmu.2021.697083. eCollection 2021. Front Immunol. 2021. PMID: 34295338 Free PMC article. Review.

5

Comprehensive analysis of prognostic immune-related genes and drug sensitivity in cervical cancer.

Pi YN, Guo JN, Lou G, Cui BB. Pi YN, et al. Cancer Cell Int. 2021 Dec 1;21(1):639. doi: 10.1186/s12935-021-02333-9. Cancer Cell Int. 2021. PMID: 34852825 Free PMC article.

6

Identification and Validation in a Novel Quantification System of Ferroptosis Patterns for the Prediction of Prognosis and Immunotherapy Response in Left- and Right-Sided Colon Cancer.

Zhang HC, Deng SH, Pi YN, Guo JN, Xi H, Shi X, Yang XF, Zhang BM, Xue WN, Cui BB, Liu YL. Zhang HC, et al. Front Immunol. 2022 Apr 4;13:855849. doi: 10.3389/fimmu.2022.855849. eCollection 2022. Front Immunol. 2022. PMID: 35444656 Free PMC article.

7

Corrigendum: Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic Potential.

Pi YN, Qi WC, Xia BR, Lou G, Jin WL. Pi YN, et al. Front Immunol. 2022 Apr 8;13:891942. doi: 10.3389/fimmu.2022.891942. eCollection 2022. Front Immunol. 2022. PMID: 35464487 Free PMC article.

8

Loss of SMURF2 expression enhances RACK1 stability and promotes ovarian cancer progression.

Pi Y, Feng Q, Sun F, Wang Z, Zhao Y, Chen D, Liu Y, Lou G. Pi Y, et al. Cell Death Differ. 2023 Nov;30(11):2382-2392. doi: 10.1038/s41418-023-01226-w. Epub 2023 Oct 12. Cell Death Differ. 2023. PMID: 37828084 Free PMC article.

9

Clinical and prognostic significance of FBXL6 expression in ovarian cancer.

Tao D, Lou S, Huang W, Sun K, Li J, Wang Z, Pi Y, Zhao Y, Wen J, Xie Q, Meng F, Lou G. Tao D, et al. Among authors: pi y. Gene. 2025 Jan 15;933:148978. doi: 10.1016/j.gene.2024.148978. Epub 2024 Oct 3. Gene. 2025. PMID: 39368786 Free article.

10

Deubiquitinating Enzymes Orchestrate the Cancer Stem Cell-Immunosuppressive Niche Dialogue: New Perspectives and Therapeutic Potential.

Guo JN, Xia BR, Deng SH, Yang C, Pi YN, Cui BB, Jin WL. Guo JN, et al. Front Cell Dev Biol. 2021 Jun 9;9:680100. doi: 10.3389/fcell.2021.680100. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34179009 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

562 results

Search Page

Filters